Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Go back to Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
(NASDAQ: CODX) Delayed: 1.49 -0.07 (4.49%)
Previous Close $1.56    52 Week High
Open $1.60    52 Week Low
Day High $1.64    P/E N/A 
Day Low $1.47    EPS
Volume 89,446